Results 171 to 180 of about 164,106 (243)

The implementation of Next-Generation Sequencing (NGS) in a Brazilian Public Hospital: a systematic review of challenges and perspectives in oncology. [PDF]

BMC Med Genomics
Elexias SRV, Lopes BA, Acatauassú R, Dos Santos LS, Castro T, Chantre-Justino M, Amadeu TP, Carrerette FB, Ornellas MH, Pinto FBR, Loureiro L, Huertas-Vazquez A, Santiago F.   +12 more
europepmc   +1 more source

Phylogenomic use of low‐copy nuclear markers from genome skimming data: An example from Melastomataceae

TAXON, Volume 75, Issue 2, April 2026.
Abstract The emergence of conflicting signals among different genomic regions, individual genes, and inference methods has been frequently reported in phylogenomic studies. Conflicts can occur from methodological error and biological processes, and disentangling the contribution of each putative source of discordance became a major challenge.
Marcelo Reginato, Matias Köhler, Lucas C. Majure, Fabián A. Michelangeli   +3 more
wiley   +1 more source

Correction: Range-wide assessment of habitat suitability for jaguars using multiscale species distribution modelling. [PDF]

Sci Rep
Alvarenga GC, Sartor CC, Cushman SA, Zimmermann A, Srbek-Araujo AC, Mendes-Oliveira AC, Harmsen B, De Angelo C, Esteves CF, de Campos CB, Polli DJ, Viana DFP, Gräbin DM, Donadio E, Ramalho EE, Payán E, Azevedo FCC, Palomares F, Powell GVN, Ceballos G, Porfirio G, Zarza H, Cassaigne I, Bogoni JA, Sena L, Maranhão L, de Brito MRM, Tobler MW, Wiig Ø, Foster RJ, Sampaio R, Nuñez R, Morato RG, Boron V, Moreno WHA, Malhi Y, Macdonald DW, Kaszta Ż.   +37 more
europepmc   +1 more source

Legitimation and Trust Strategies for Sustainability in and for Global Sport Events: The Case of the ‘Climate Positive’ Brisbane 2032 Olympics

Business Ethics, the Environment &Responsibility, Volume 35, Issue 2, Page 1158-1168, April 2026.
ABSTRACT International sport governing bodies are increasingly under scrutiny due to their questionable environmental sustainability records of global sport events, thereby facing a potential legitimacy gap and loss of trust that the proclaimed sustainability goals can be achieved.
David M. Herold, Shannon Colville, Nadine Kathrin Ostern, Marleen Voss   +3 more
wiley   +1 more source

Nationwide epidemiological study of tuberculosis and other respiratory pathogens among children and adolescents in Brazil: TBPed Brazil study protocol. [PDF]

PLoS One
Scotta MC, Polese-Bonatto M, Varela FH, Sartor ITS, Zavaglia GO, de David CN, Fernandes IR, Azevedo TR, Barros A, Carvalho ACC, Cardoso CAA, Sant'Anna CC, Rossoni AMO, Cordeiro-Santos M, Kritski A, da Costa FD, de Souza NM, Alves ES, Zar HJ, Stein RT.   +19 more
europepmc   +1 more source

A global overview of pterosaur ichnology: tracksite distribution in space and time [PDF]

, 2008
Harris, Jerald D., Lockley, Martin, Mitchell, Laura   +2 more
core   +1 more source

Effect of Eplontersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy Across Genetic Variants: An Exploratory Analysis From the NEURO‐TTRansform Trial

European Journal of Neurology, Volume 33, Issue 4, April 2026.
In this exploratory analysis of the NEURO‐TTRansform Phase 3 trial, the efficacy of eplontersen was evaluated in patients with early‐ or late‐onset Val30Met (p.Val50Met) or non‐Val30Met hereditary transthyretin amyloidosis with polyneuropathy. Eplontersen halted neuropathy impairment as measured by the mNIS+7 composite score and improved Norfolk QoL‐DN
Julian D. Gillmore, David Adams, Markus Weiler, Ahmad Masri, Laura Obici, Jonatan Nåtman, T. Jesse Kwoh, Barry Reicher, James Revkin, Márcia Waddington Cruz, Morie Gertz, Chi‐Chao Chao   +11 more
wiley   +1 more source

Issue Information

CNS Neuroscience &Therapeutics, Volume 32, Issue 4, April 2026.
wiley   +4 more sources

Factors associated with poor sleep health in adults at risk for obstructive sleep apnea. [PDF]

Sleep Breath
Pereira JM, Duarte RLM, Cozer K, Fernandes APD, Mello LF, Mello FCQ, Gozal D.   +6 more
europepmc   +1 more source

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 4, Page 939-949, April 2026.
Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza, Víctor Obach, Daniel Guisado‐Alonso, Fernando Velasco Juanes, Rocío Álvarez Escudero, María Martín Bujanda, Sonsoles Aranceta, Aintzine Ruisánchez, Natalia Roncero, Ane Mínguez‐Olaondo, Amaya Echeverria, Alba López‐Bravo, Ángel Luis Guerrero‐Peral, David García‐Azorín, Elisa Cuadrado‐Godia, Galca‐Only Study Group, Neus Fabregat, Marta Ruibal, Izaro Kortazar Zubizarreta, Nuria Riesco, Lucia González‐Fernández, Paula Manera, Agustín Oterino Duran, Yésica González‐Osorio, Santiago Fernández‐Fernández, Juan Carlos García‐Moncó, Isabel Fernández‐Pérez, Joan Jiménez‐Balado   +27 more
wiley   +1 more source